Sagimet Biosciences Inc. SEC filings SGMT
Sagimet Biosciences Inc. has 262 filings in SEC EDGAR's recent list, going back to May 8, 2007. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2026 | Oct 22, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 7, 2026 | — |
| 8-K |
Current report
Material agreement
|
Oct 1, 2026 | Sep 30, 2026 |
| 424B5 | Prospectus supplement | Oct 1, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 424B3 | Prospectus | Sep 30, 2026 | — |
| 4 | Insider transaction | Aug 17, 2026 | Aug 14, 2026 |
| 144 | Notice of proposed sale | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 12, 2026 | Aug 11, 2026 |
| 144 | Notice of proposed sale | Aug 11, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 30, 2026 | — |
| 4 | Insider transaction | Jul 22, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jul 22, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jul 22, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 21, 2026 | Jul 20, 2026 |
| 144 | Notice of proposed sale | Jul 20, 2026 | — |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 14, 2026 | Apr 20, 2026 |
| 3 | Initial insider ownership | May 14, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
Apr 28, 2026 | Apr 27, 2026 |
| 424B5 | Prospectus supplement | Apr 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 27, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Apr 27, 2026 | Apr 27, 2026 |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 21, 2026 | Apr 20, 2026 |
| S-8 | Employee stock plan registration | Mar 11, 2026 | — |
| S-8 | Employee stock plan registration | Mar 11, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2026 | Mar 11, 2026 |
| 10-K | Annual report | Mar 11, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 2, 2026 | Feb 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Other events
|
Dec 17, 2025 | Dec 17, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 20, 2025 |
| 144 | Notice of proposed sale | Nov 20, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Nov 6, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Auditor change
|
Aug 22, 2025 | Aug 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Aug 14, 2025 | Aug 14, 2025 |
| 424B5 | Prospectus supplement | Aug 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 23, 2025 | Jul 21, 2025 |
| 4 | Insider transaction | Jul 23, 2025 | Jul 21, 2025 |
| 4 | Insider transaction | Jul 23, 2025 | Jul 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 24, 2025 | — |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 10, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 20, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| UPLOAD | Letter from the SEC | May 7, 2025 | — |
| CORRESP | Letter to the SEC | May 5, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2025 | Apr 29, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 9, 2025 |
| UPLOAD | Letter from the SEC | Apr 22, 2025 | — |
| S-8 | Employee stock plan registration | Mar 12, 2025 | — |
| S-8 | Employee stock plan registration | Mar 12, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
Mar 12, 2025 | Mar 12, 2025 |
| 10-K | Annual report | Mar 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Mar 11, 2025 | Mar 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 14, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 6, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 6, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 6, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Other events
|
Jan 2, 2025 | Jan 2, 2025 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| EFFECT | Filing | Aug 26, 2024 | — |
| CORRESP | Letter to the SEC | Aug 22, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2024 | — |
| 8-K |
Current report
Material agreement
|
Aug 16, 2024 | Aug 15, 2024 |
| S-3 | Shelf registration | Aug 15, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Aug 5, 2024 | Aug 1, 2024 |
| 4 | Insider transaction | Aug 5, 2024 | Aug 1, 2024 |
| 3 | Initial insider ownership | Aug 5, 2024 | Aug 1, 2024 |
| 3 | Initial insider ownership | Aug 5, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 1, 2024 | Jul 30, 2024 |
| 4 | Insider transaction | Jul 25, 2024 | Jul 23, 2024 |
| 144 | Notice of proposed sale | Jul 23, 2024 | — |
| 4 | Insider transaction | Jul 23, 2024 | Jul 19, 2024 |
| 4 | Insider transaction | Jul 23, 2024 | Jul 19, 2024 |
| 4 | Insider transaction | Jul 23, 2024 | Jul 19, 2024 |
| 8-K |
Current report
Other events
|
Jul 2, 2024 | Jul 2, 2024 |
| 8-K/A |
Amended current report
Other events
|
Jun 13, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 23, 2024 | May 23, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 3 | Initial insider ownership | May 8, 2024 | May 6, 2024 |
| 8-K |
Current report
Officer or director change
|
May 6, 2024 | May 3, 2024 |
| ARS | Annual report to shareholders | Apr 18, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 18, 2024 | — |
| DEF 14A | Proxy statement | Apr 18, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 3 | Initial insider ownership | Apr 3, 2024 | Apr 1, 2024 |
| 3 | Initial insider ownership | Apr 3, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| S-8 | Employee stock plan registration | Mar 25, 2024 | — |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 25, 2024 | Mar 20, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 11, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 5, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2024 | Jan 31, 2024 |
| 3 | Initial insider ownership | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Jan 31, 2024 | Jan 29, 2024 |
| 4 | Insider transaction | Jan 31, 2024 | Jan 29, 2024 |
| 4 | Insider transaction | Jan 31, 2024 | Jan 29, 2024 |
| 4 | Insider transaction | Jan 31, 2024 | Jan 29, 2024 |
| 4 | Insider transaction | Jan 31, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Other events
|
Jan 30, 2024 | Jan 25, 2024 |
| 424B4 | Prospectus | Jan 29, 2024 | — |
| EFFECT | Filing | Jan 25, 2024 | — |
| 8-K |
Current report
Results of operations
|
Jan 24, 2024 | Jan 23, 2024 |
| S-1/A | Amended registration statement | Jan 24, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| S-1 | Registration statement | Jan 23, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 22, 2024 | Jan 22, 2024 |
| UPLOAD | Letter from the SEC | Jan 16, 2024 | — |
| DRS | Filing | Jan 10, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 8, 2023 | Dec 7, 2023 |
| 4 | Insider transaction | Nov 21, 2023 | Nov 17, 2023 |
| 4 | Insider transaction | Nov 21, 2023 | Nov 17, 2023 |
| 4 | Insider transaction | Nov 21, 2023 | Nov 17, 2023 |
| 4 | Insider transaction | Nov 21, 2023 | Nov 17, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2023 | Nov 17, 2023 |
| 4 | Insider transaction | Nov 20, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 27, 2023 | Sep 27, 2023 |
| SC 13G | Ownership over 5% (passive) | Sep 11, 2023 | — |
| 4 | Insider transaction | Sep 8, 2023 | Sep 7, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 21, 2023 | Aug 21, 2023 |
| 10-Q | Quarterly report | Aug 21, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2023 | Jul 21, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SGMT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1400118
- Former names
- 3-V Biosciences, Inc. (until Feb 25, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.